advertisement

Accelerate your drug discovery pipeline with AI-powered molecular modelling

BioSim Pro · Trusted by 400+ research institutions globally · 30-day free trial

CRISPR base editing corrects sickle cell mutation in 97% of patient cells · Phase III mRNA cancer vaccine shows 44% reduction in recurrence · Gut microbiome linked to treatment-resistant depression — Nature study · Novo Nordisk acquires rare disease biotech for $3.2B · FDA grants breakthrough designation to novel Alzheimer's antibody ·
CRISPR base editing corrects sickle cell mutation in 97% of patient cells · Phase III mRNA cancer vaccine shows 44% reduction in recurrence · Gut microbiome linked to treatment-resistant depression — Nature study · Novo Nordisk acquires rare disease biotech for $3.2B · FDA grants breakthrough designation to novel Alzheimer's antibody ·

NIH K99/R00 Pathway to Independence Award — 2026 cycle open

Deadline: 12 May 2026
3668

The NIH K99/R00 Pathway to Independence Award remains one of the most prestigious funding opportunities for early-career researchers, and the 2026 cycle is now open for applications. Designed to support postdoctoral scientists in transitioning to independent research careers, this award provides a unique two-phase funding structure that bridges the gap between mentored training and faculty-level independence.

The initial K99 phase offers up to two years of mentored support, allowing researchers to strengthen their skills, expand their research portfolio, and prepare for independent positions. This is followed by the R00 phase, which provides up to three years of funding once the recipient secures a tenure-track or equivalent research role. Together, these phases enable a smooth and well-supported transition into independent scientific leadership.

The program is highly competitive and encourages applicants from diverse biomedical and behavioral research fields. Candidates are evaluated based on their research proposal, career development plan, mentorship, and potential to become impactful independent investigators.

With the 2026 cycle now open, eligible postdoctoral researchers are encouraged to begin preparing strong, well-structured applications. Securing a K99/R00 award not only provides financial support but also enhances career credibility, positioning recipients for long-term success in academia and research.

Facebook
Twitter
LinkedIn

Get the free newsletter

Top news, trends & analysis from Biomed Today.

No spam · Unsubscribe anytime

Advertisement

MolDock Suite

MD simulation for academic & pharma teams.

Advertisement

Your advertisement here

Advertisement

Your advertisement here